Toronto Woman Battles Denied Out-of-Country Cancer Treatment by Ontario Government

a stack of thick medical files and plain manila folders resting on a wooden desk in a clinic office, beside a stethoscope, with an out-of-focus view of a typica

AI-generated illustration; not a photograph of the reported event.

Cancer Patient Faces Barrier to Accessing U.S. Treatment

A Toronto woman, Sabrina Apitz-Grossman, faces a critical challenge in her battle with cancer as she is denied out-of-country cancer treatment coverage by the Ontario government. Despite clinical recommendations supporting the specialized therapy available only in the United States, the province has refused to fund her care.

Initial Diagnosis and Medical Recommendation

Apitz-Grossman, who was first diagnosed with cancer at 28, describes her experience as an ongoing dual struggle: "It’s felt like two fights. It’s felt like the fight against the cancer and then also the fight to try to access treatment." Following a recurrence of the disease in her lungs, her doctors advised that the best option was Tecelra, a personalized T-cell therapy offered in the U.S. Ontario Health’s clinical expert review supported this recommendation, with one government document stating, "I think an alternative treatment would be worth trying," and official correspondence noting, "both CERs [Clinical Expert Reviews] have said yes."

Official Denial of Out-of-Country Treatment

Despite endorsements from multiple experts, Apitz-Grossman received a letter from the Ministry of Health denying her application for coverage. She expressed frustration: "Everyone who’s consulted says yes. And yet you can’t get your hands on it. You can’t put your finger on it. You can’t access it." Tecelra is a therapy made from a patient’s own T-cells, which her oncologist says yields a nearly 50% response rate, with a 90% survival chance after a year for responders and 70% after two years. However, its cost is substantial—US$727,000.

Political Fallout and Legislative Debate

The case ignited heated exchanges at Queen’s Park. MPP Robin Lennox accused Ontario Health Minister Sylvia Jones of lying about the expert recommendations, leading to Lennox’s removal from the legislature chamber after refusing to withdraw her remarks. “This is the treatment that she needs and that she meets eligibility for the out-of-country coverage program,” Lennox argued. Liberal critic Adil Shamji further criticized ongoing delays, stating, “Every time the Minister of Health kicks the can down the road, she’s causing patients like Sabrina to lose time.” Health Minister Jones denied the decisions were political, insisting they were "based on expert assessments."

Ongoing Fight and Legal Action

With her health and future at stake, Apitz-Grossman continues her pursuit of the treatment she needs. After her health services appeal was denied by the province’s review board, she has decided to take her case to court. The matter has been expedited and is scheduled for a hearing within weeks. In her own words, “You have this shot at life. I could see my 40th birthday. I could see my 50th. I could turn 90.”

Looking Ahead

Apitz-Grossman's experience places a spotlight on the challenges some Canadian patients face in obtaining approval for potentially life-saving cross-border healthcare, particularly when expert assessments support such requests. Her legal case may set a precedent for similar disputes in Ontario’s healthcare system.